GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » Acadia Healthcare Co Inc (NAS:ACHC) » Definitions » Change In Receivables
中文

Acadia Healthcare Co (Acadia Healthcare Co) Change In Receivables : $-39 Mil (TTM As of Dec. 2023)


View and export this data going back to 2011. Start your Free Trial

What is Acadia Healthcare Co Change In Receivables?

Acadia Healthcare Co's change in receivables for the quarter that ended in Dec. 2023 was $1 Mil. It means Acadia Healthcare Co's Accounts Receivable declined by $1 Mil from Sep. 2023 to Dec. 2023 .

Acadia Healthcare Co's change in receivables for the fiscal year that ended in Dec. 2023 was $-39 Mil. It means Acadia Healthcare Co's Accounts Receivable increased by $39 Mil from Dec. 2022 to Dec. 2023 .

Acadia Healthcare Co's Accounts Receivable for the quarter that ended in Dec. 2023 was $361 Mil.

Days Sales Outstanding measures of the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed. Acadia Healthcare Co's Days Sales Outstanding for the three months ended in Dec. 2023 was 44.40.

In Ben Graham's calculation of liquidation value, Apple Inc's Accounts Receivable are only considered to be worth 75% of book value. Acadia Healthcare Co's liquidation value for the three months ended in Dec. 2023 was $-2,097 Mil.


Acadia Healthcare Co Change In Receivables Historical Data

The historical data trend for Acadia Healthcare Co's Change In Receivables can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Acadia Healthcare Co Change In Receivables Chart

Acadia Healthcare Co Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Change In Receivables
Get a 7-Day Free Trial Premium Member Only Premium Member Only -18.71 15.34 2.45 -41.98 -39.01

Acadia Healthcare Co Quarterly Data
Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23
Change In Receivables Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -6.44 -23.97 0.57 -16.83 1.22

Acadia Healthcare Co Change In Receivables Calculation

Change In Accounts Receivable relative to the previous period. It is any increase or decrease in the cash a company is owed by its customers.

Change In Receivables for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was $-39 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Acadia Healthcare Co  (NAS:ACHC) Change In Receivables Explanation

1. Accounts Receivable are created when a customer has received a product but has not yet paid for that product. Days Sales Outstanding measures of the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed.

Acadia Healthcare Co's Days Sales Outstanding for the quarter that ended in Dec. 2023 is calculated as:

Days Sales Outstanding
=Accounts Receivable/Revenue*Days in Period
=361.451/742.8*91
=44.40

2. In Ben Graham's calculation of liquidation value, Acadia Healthcare Co's accounts receivable are only considered to be worth 75% of book value:

Acadia Healthcare Co's liquidation value for the quarter that ended in Dec. 2023 is calculated as:

Liquidation Value
=Cash, Cash Equivalents, Marketable Securities-Total Liabilities+(0.75 * Accounts Receivable)+(0.5 * Total Inventories)
=100.073-2471.181+0.75 * 361.451+0.5 * 5.3
=-2,097

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Acadia Healthcare Co Change In Receivables Related Terms

Thank you for viewing the detailed overview of Acadia Healthcare Co's Change In Receivables provided by GuruFocus.com. Please click on the following links to see related term pages.


Acadia Healthcare Co (Acadia Healthcare Co) Business Description

Traded in Other Exchanges
Address
6100 Tower Circle, Suite 1000, Franklin, TN, USA, 37067
Acadia Healthcare Co Inc acquires and develops behavioral healthcare facilities in the United States, United Kingdom, and Puerto Rico. Acute inpatient psychiatric facilities and specialty treatment facilities contribute the vast majority of Acadia's revenue in the United States. The U.S. facilities receive the largest proportion of payments from Medicaid, with the second-largest proportion from commercial payors. In the United Kingdom, the majority of Acadia's revenue comes from its healthcare facilities, and virtually all of the payment received is from the National Health Service.
Executives
Debra K Osteen director, officer: Chief Executive Officer 367 SOUTH GULPH ROAD, KING PRUSSIA PA 19406
John S. Hollinsworth officer: EVP of Operations 6100 TOWER CIRCLE, SUITE 1000, FRANKLIN TN 37067
Patrice A Harris director 514 MARKET ST., PARKERSBURG WV 26101
Brian Farley officer: EVP , GC and Secretary 222 MERCHANDISE MART PLAZA, SUITE 2024, CHICAGO IL 60654
Heather Brianne Dixon officer: Chief Financial Officer AETNA INC., 151 FARMINGTON AVENUE, HARTFORD CT 06156
William Grieco director 830 CRESCENT CENTRE DRIVE, SUITE 610, FRANKLIN TN 37067
William M Petrie director 310 25TH AVENUE NORTH, SUITE 309, NASHVILLE TN 37203
Ralph David Kelly director 4005 WOOD LAKE DRIVE, PLANO TX 75093
Christopher H. Hunter director, officer: Chief Executive Officer 500 W MAIN STREET, LOUISVILLE KY 40202
Reeve B Waud director, 10 percent owner 300 N LASALLE ST, SUITE 4900, CHICAGO IL 60654
David M. Duckworth officer: Chief Financial Officer 830 CRESCENT CENTRE DRIVE, SUITE 610, FRANKLIN TN 37067
Christopher L Howard 10 percent owner, officer: EVP, GC and Secretary 830 CRESCENT CENTRE DRIVE, SUITE 610, FRANKLIN TN 37067
Michael Fucci director 6100 TOWER CIR #1000, FRANKLIN TN 37067
Jason Bernhard director 6100 TOWER CIRCLE, SUITE 1000, FRANKLIN TN 37067
Laurence L. Harrod officer: EVP of Finance 6100 TOWER CIRCLE, SUITE 1000, FRANKLIN TN 37067